Y Intercept (Hong Kong) LTD Nektar Therapeutics Transaction History

Y Intercept (Hong Kong) LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$0.49 - $0.96 $62,506 - $122,461	127,564 New	127,564 $118,000
Q2 2023 Aug 14, 2023	BUY	$0.53 - $1.03 $165,361 - $321,363	312,003 New	312,003 $180,000
Q4 2021 Feb 14, 2022	SELL	$10.83 - $18.41 $115,718 - $196,710	-10,685 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.07 - $18.84 $139,652 - $201,305	10,685 New	10,685 $192,000
Q1 2021 May 12, 2021	SELL	$16.56 - $25.46 $268,950 - $413,495	-16,241 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$15.77 - $19.03 $256,120 - $309,066	16,241 New	16,241 $291,000

140

135M

32.8K

55.5K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.